Danish biotech company raises 60 million for psoriasis drug
A Danish biotech company is on the verge of marketing a new drug candidate. A financing round that generated millions is set to help the company reach its target.
by Leonora Beck
Zealand Pharma is not the only biotech company to take a candidate drug all the way to the market. Another Danish biotech company could now be going global with a new psoriasis drug.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
